Skip to content
Clinical Trials – home
LithuaniaBack to Lithuania

Clinical trials in Panevezys – page 2

16 clinical trials in Panevezys, Lithuania. Every trial is listed in the EU Clinical Trials Register and updated daily.

LithuaniaOur site in LithuaniaKlinikiniai-Tyrimai.lt(opens in a new tab)
Panevezys at a glance
16
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

16 trials in Panevezys

Open in trial search
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Colitis ulcerative

Not recruiting
Investigational
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Tamuzimod Acetate
  • Sponsor:Oppilan Pharma Limited
Countries:LithuaniaLithuania
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Etrasimod Arginine
  • Sponsor:Arena Pharmaceuticals Inc.
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Tovinontrine
  • Sponsor:Cardurion Pharmaceuticals Inc.

Other cities in Lithuania

The busiest research cities in the country

All 10 cities in Lithuania

Clinical research in Panevezys

What the registry says about research in the country

01 Inflammatory Bowel Disease Research

Multiple clinical trials focusing on ulcerative colitis treatments, investigating novel therapeutic approaches including mirikizumab, etrasimod, and VTX002 for patients with moderate to severe conditions.

  • Ulcerative Colitis Management
  • Novel Treatment Evaluation
  • Long-term Therapy Assessment

Additional research includes studies on Crohn's Disease with targeted therapeutic approaches.

02 Cardiovascular Disease Studies

Comprehensive research into atherosclerotic cardiovascular disease prevention and treatment, including trials of inclisiran for reducing major adverse cardiovascular events.

  • Heart Attack Prevention
  • Stroke Risk Reduction
  • Cardiovascular Death Prevention

Studies include both primary prevention and management of established cardiovascular conditions.

03 Heart Function Research

Innovative studies examining treatments for heart failure with reduced ejection fraction and acute cardiac conditions, including investigation of tovinontrine and selatogrel.

  • Acute Myocardial Infarction
  • Heart Failure Management
  • Emergency Cardiac Care

Focus on both immediate intervention and long-term cardiac health improvement.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.